The European Pharmacopoeia and the British Pharmacopoeia have worked together to make supportive pharmacopoeial texts (monographs, general chapters, appendices and supplementary chapters) available for a limited period of time at no cost to users.

This is to support those developing, manufacturing or testing these substances and products during this challenging period. These texts will be kept under review and updated and withdrawn as required. 

• More information on EDQM contributions to the protection of public health in the COVID-19 pandemic here.